Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05FUU
|
||||
| Former ID |
DIB012715
|
||||
| Drug Name |
Pratosartan
|
||||
| Synonyms |
KD3-671; KT3-671
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Phase 3 | [545261] | ||
| Company |
Kotobuki Pharmaceutical Co Ltd
|
||||
| Formula |
C25H26N6O
|
||||
| Canonical SMILES |
n1(c2c(nc1CCC)CCCCC2=O)Cc1ccc(c2c(c3nnn[nH]3)cccc2)cc1
|
||||
| CAS Number |
CAS 153804-05-8
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Type-1 angiotensin II receptor | Target Info | Antagonist | [529390] | |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | Arf6 trafficking events | ||||
| Arf6 signaling events | |||||
| Angiopoietin receptor Tie2-mediated signaling | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| Muscle/Heart Contraction | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.